MedPath

PROVIDING OXYGEN BY NASAL PRONGS AT FLOW MORE THAN 2 LITRES PER MINUTE VERSUS PROVIDING OXYGEN WITH NASAL PRONGS USING CPAP DEVICE IN CHILDREN WITH DIFFICULTY IN BREATHING.

Not yet recruiting
Conditions
Unspecified acute lower respiratory infection,
Registration Number
CTRI/2023/05/052491
Lead Sponsor
Motukuri Sesha Sarat Chandra
Brief Summary

To compare out comes of humidified high flow nasal cannula versus continuous positive airway pressure in children of respiratory distress presenting to tertiary care hospital Aurangabad.

Primary objective:

To compare success rate/failure rate between HFNC & CPAP treatment group.

(success is defined if patient is started on non-invasive ventilation and does not require invasive ventilation throughout the course,

Failure is defined as if patient requiring invasive ventilation after non-invasive ventilation)

Secondary objective:

To study complications like abdominal distension, issue of feeding intolerance, nasal mucosal injury, discharge on oxygen supplementation & prolonged ICU stay.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

All children from 1 month to 18 years having Respiratory distress.

Exclusion Criteria

Intubation on admission Children with congenital heart diseases Children with neurological diseases Covid positive patients Children with chest wall deformity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success & failure rate of the intervention done. Success is defined as patient not requiring invasive ventilation after the intervention. Failure is defined as patient requiring invasive ventilation.Assessed from time of admission till 72 hours of intervention
Secondary Outcome Measures
NameTimeMethod
Document complications like abdominal distension, feeding intolerance, nasal mucosal injury, prolonged ICU stay and discharge on oxygen supplementationAfter starting intervention till discharge or death

Trial Locations

Locations (1)

MGM Medical College

🇮🇳

Aurangabad, MAHARASHTRA, India

MGM Medical College
🇮🇳Aurangabad, MAHARASHTRA, India
Motukuri Sesha Sarat Chandra
Principal investigator
8096692642
sc73010@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.